SecBot SecBot
PRESS-RELEASE ·Filed Nov 4, 2026

BDX

BD (Becton, Dickinson and Company)
NEUTRAL
Impact 2/10
Horizonweeks Processed12d 16h ago WireGlobeNewswire
Press release · Leadership
Actionable Insight • Neutral

Monitor for any strategic shifts in the Peripheral Intervention unit under new leadership, but no immediate financial read-through expected.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$209.19
T+0 close · Nov 4, 2026 · via day close
Latest settled
+2.55%
T+5 · $214.52
Vs SPY
+3.46%
α at T+5
Next horizon
T+20
in 16d
  1. T+0 · Nov 4 $209.19entry
  2. T+1 · 12d ago +2.08%α +6.49% · $213.55
  3. T+5 · 6d ago +2.55%α +3.46% · $214.52
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BD appointed Bridget Bagnato as worldwide president of its Peripheral Intervention business unit, effective November 16. Bagnato, a 27-year BD veteran, previously led the Specimen Management unit and will report to the Interventional segment president. The change is a routine leadership rotation with no disclosed financial impact.

Key Facts

  • Bridget Bagnato appointed worldwide president of Peripheral Intervention, effective November 16
  • Bagnato previously served as worldwide president of BD's Specimen Management business unit
  • She has over 27 years at BD in various leadership roles
  • She will report to Peter Menziuso, EVP and president of the Interventional segment
  • Based in Tempe, Arizona

Financial Impact

No financial figures disclosed; routine leadership change

Risk Factors

  • No material risks identified from this appointment

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
57% bullish (21 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302928462

Track record

17 reports on BDX

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Entry $214.52 Now $216.47 +0.91% settles Nov 18
  2. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
  3. Nov 5, 202611d ago 144 Neutral 2/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
  4. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
  5. Nov 5, 202611d ago Press Release Neutral 3/10 Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
  6. Nov 4, 202612d ago Press Release Neutral 2/10 Viewing Entry $209.19 to $214.52 Now $216.47 +3.48% ▲ +2.55% +3.46% vs SPY
  7. Oct 26, 202621d ago 144 Neutral 2/10 Entry $195.03 to $198.17 Now $216.47 +10.99% ▲ +1.61% +3.60% vs SPY
  8. Oct 6, 20265w ago Press Release Neutral 2/10 Entry $180.30 to $187.37 Now $216.47 +20.06% ▲ +3.92% +4.06% vs SPY
  9. Aug 14, 202613w ago Insider Cluster Neutral 2/10 Entry $182.09 to $190.74 Now $216.47 +18.88% ▲ +4.75% +5.94% vs SPY
  10. Jul 22, 202616w ago 8-K Neutral 2/10 Entry $153.16 to $168.40 Now $216.47 +41.34% ▲ +9.95% +12.35% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (9h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026